Shots:

• Roche launches cobas Zika test for use on the cobas 6800/8800 Systems to identify Zika virus RNA in human plasma and is intended to utilize in screening blood donations
• The launch of cobas Zika test fortify Roche’s donor screening portfolio for blood-borne diseases in the CE market and minimize the risk of transmission via infected blood and plasma transfusion
•  The cobas Zika test is qualitative in vitro nucleic acid screening test for the direct detection of Zika virus RNA in plasma specimens from donors of whole blood and blood components. The test provides solutions for blood services to detect Zika Virus and ensure that infected blood is not made available for transfusion

Click here to­ read full press release/ article 

Ref: Roche | Image: Roche